INDUSTRIAL SPACE LEASEIndustrial Space Lease • February 2nd, 2015 • XBiotech Inc. • Pharmaceutical preparations
THIS INDUSTRIAL SPACE LEASE (“Lease”), made as of the 16th day of August, 2010 by and between NNN Met Center 4-9, LP, a Texas limited partnership (“Landlord”), and XBiotech USA, Inc., a Delaware corporation (“Tenant”);
Re: Change in Control AgreementChange in Control Agreement • February 2nd, 2015 • XBiotech Inc. • Pharmaceutical preparations • British Columbia
XBiotech Inc. (the “Company”) considers it essential to the best interests of its members to foster the continuous employment of its senior executive officers. In this regard, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its members that appropriate steps should be taken to reinforce and encourage management’s continued attention, dedication and availability to the Company in the event of a Potential Change in Control (as defined in Section 2), without being distracted by the uncertainties which can arise from any possible changes in control of the Company.
EXECUTIVE EMPLOYMENT AGREEMENT XBIOTECH INC.Executive Employment Agreement • February 2nd, 2015 • XBiotech Inc. • Pharmaceutical preparations • British Columbia
This Agreement confirms the terms and conditions of your employment by the Company and will constitute your employment agreement. Those terms and conditions are set out below:
INDEMNITY AGREEMENTIndemnification & Liability • February 2nd, 2015 • XBiotech Inc. • Pharmaceutical preparations • British Columbia
XBIOTECH INC., a company duly incorporated under the laws of the Province of British Columbia, and having a registered office at 2500 – 700 West Georgia Street, Vancouver, British Columbia, V7Y 1B3
Board Member AgreementBoard Member Agreement • February 2nd, 2015 • XBiotech Inc. • Pharmaceutical preparations • New York
This Agreement (this “Agreement”), dated as of the 4th day of November 2014, is between, Daniel Vasella, an individual having a residence at , (the “Board Director”), and XBiotech Inc., a Canadian corporation with a place of business at 300-1055 West Hastings Street, Vancouver BC V6E 2E9 Canada (the “Company”).
